Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer

Figure 1 Five and 10 years biochemical relapse free survival rates when castrate testosterone level of < 20 ng/dL is used (P = 0. 001).

Figure 2 Five and 10 years biochemical relapse free survival rates when castrate testosterone level of < 50 ng/dL is used (P = 0. 006).

Figure 3 Biochemical relapse free survival rates for patients with different castrate testosterone cut-off values (P = 0. 003).

Figure 4 Receiver operating characteristic curve analyses comparing 2 cut-off castrate testosterone values.